Compare Envista Holdings Corp. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROCE of 6.67%
- The company has been able to generate a Return on Capital Employed (avg) of 6.67% signifying low profitability per unit of total capital (equity and debt)
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 5.77
3
Poor long term growth as Net Sales has grown by an annual rate of 2.21% over the last 5 years
4
Negative results in Jun 25
5
With ROCE of 4.03%, it has a risky valuation with a 1.04 Enterprise value to Capital Employed
Stock DNA
Pharmaceuticals & Biotechnology
USD 4,100 Million (Small Cap)
61.00
NA
0.00%
0.09
2.18%
1.32
Revenue and Profits:
Net Sales:
751 Million
(Quarterly Results - Dec 2025)
Net Profit:
33 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
18.06%
0%
18.06%
6 Months
23.9%
0%
23.9%
1 Year
54.98%
0%
54.98%
2 Years
21.11%
0%
21.11%
3 Years
-31.64%
0%
-31.64%
4 Years
-48.09%
0%
-48.09%
5 Years
-34.86%
0%
-34.86%
Envista Holdings Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.57%
EBIT Growth (5y)
2.82%
EBIT to Interest (avg)
5.77
Debt to EBITDA (avg)
1.35
Net Debt to Equity (avg)
0.12
Sales to Capital Employed (avg)
0.53
Tax Ratio
3.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
6.67%
ROE (avg)
5.51%
Valuation key factors
Factor
Value
P/E Ratio
61
Industry P/E
Price to Book Value
1.32
EV to EBIT
17.83
EV to EBITDA
12.11
EV to Capital Employed
1.29
EV to Sales
1.61
PEG Ratio
1.22
Dividend Yield
NA
ROCE (Latest)
7.26%
ROE (Latest)
2.18%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 87 Schemes (65.56%)
Foreign Institutions
Held by 141 Foreign Institutions (15.06%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
750.60
669.90
12.05%
Operating Profit (PBDIT) excl Other Income
109.60
94.00
16.60%
Interest
10.30
9.00
14.44%
Exceptional Items
-7.20
-7.30
1.37%
Consolidate Net Profit
32.90
-30.30
208.58%
Operating Profit Margin (Excl OI)
107.20%
96.70%
1.05%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 12.05% vs -1.79% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 208.58% vs -214.77% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,719.50
2,510.60
8.32%
Operating Profit (PBDIT) excl Other Income
361.40
266.20
35.76%
Interest
36.60
46.40
-21.12%
Exceptional Items
-29.30
-1,181.30
97.52%
Consolidate Net Profit
47.00
-1,118.60
104.20%
Operating Profit Margin (Excl OI)
90.20%
57.00%
3.32%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 8.32% vs -2.18% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 104.20% vs -1,016.37% in Dec 2024
About Envista Holdings Corp. 
Envista Holdings Corp.
Pharmaceuticals & Biotechnology
Envista Holdings Corporation is a dental products company. The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Company operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Company Coordinates 
Company Details
200 S Kraemer Blvd Bldg E , BREA CA : 92821-6208
Registrar Details






